Get my own profile
Public access
View all31 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Manmohan SinghBeam TxVerified email at beamtx.com
- Rino RappuoliBiotecnopolo di SienaVerified email at biotecnopolo.it
- Luis A. BritoBeam TherapeuticsVerified email at beamtx.com
- Nicholas ValianteCEO, Glyde Bio, Inc.Verified email at glydebio.com
- Ed C LavelleSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College DublinVerified email at tcd.ie
- Andreas WackFrancis Crick Institute, London, UKVerified email at crick.ac.uk
- Mariagrazia PizzaGSK Vaccines - Imperial CollegeVerified email at imperial.ac.uk
- Kingston MillsTrinity College DublinVerified email at tcd.ie
- Durdana RahmanKings CollegeVerified email at kcl.ac.uk
- Stephen Challacombe; ProfessorKing's College LondonVerified email at kcl.ac.uk
- Michael HoughtonVerified email at ualberta.ca
- Philip R DormitzerGSKVerified email at gsk.com
- David SkibinskiCurevo VaccineVerified email at curevovaccine.com
- Roberto AdamoGSKVerified email at gsk.com
- Rushit N LodayaExpert Scientist, GSK VaccinesVerified email at northeastern.edu
- Sylvie BertholetDirector Preclinical Evidence Generation, Preclinical R&D, GSK Vaccines, Rockville MDVerified email at gsk.com
- Mansoor M AmijiNortheastern University, Boston, MassachusettsVerified email at northeastern.edu
- Yvonne PerrieProfessor in Drug DeliveryVerified email at strath.ac.uk
- Samuele CalabroRoche GlycartVerified email at roche.com
- Alessandro MuzziGSKVerified email at gsk.com